The groundbreaking innovation of the ACTIV-FLO System in PRECISION7 is a unique combination of a water-loving moisturizing agent embedded in the lens matrix and a proprietary replenishing agent that ...

Analyst Jeff Johnson of Robert W. Baird maintained a Buy rating on Alcon (ALC – Research Report), retaining the price target of $110.00.

Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...

We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...

Alcon, the global eyecare company with manufacturing and research facilities in Berks County, reported third quarter results ...

Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on ALC stock, giving a Buy rating yesterday. Anthony Petrone has ...

Comfort was the name of the game when OT spoke with contact lens manufacturers and suppliers about recent trends and launches ...

Alcon Inc (ALC) reports strong international growth and prepares for new product launches despite facing competitive pressures in the US market.

Alcon, Inc. ALC delivered core earnings per share (EPS) of 81 cents for the third quarter of 2024, up 22.7% from the year-ago ...

1,3-4* “We are making history with the bold innovation of PRECISION7,” said Max Wolf, General Manager, Head of Vision Care and Contact Lenses at Alcon. “Now, patients can start and end every ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of PRECISION7®, the only one-week replacement contact lens with ...